Header image

Poster Tour 06: Emerging Risks, Evolving Responses: Enhancing Health Across Communities and Borders

Tracks
Track 5
Friday, October 17, 2025
11:10 AM - 11:35 AM

Speaker

Miss Chinonso Agbo
Pharmacist
Federal Road Safety Corps Medical Center

USE AND RISK PERCEPTION OF NITROUS OXIDE (LAUGHING GAS OR BALLOONS): A CROSS-SECTIONAL SURVEY AMONG ADOLESCENTS AND YOUNG ADULTS LIVING IN FEDERAL CAPITAL TERRITORY, NIGERIA

11:10 AM - 11:15 AM

Abstract (.pdf)

Biography

Agbo Chinonso Anne is a 26 years old zealous pharmacist born and raised in the federal capital of Nigeria with intense love for public health, from her secondary school days she have achieved milestone in healthcare, from volunteering to helping neighbors around her feel better
Dr Brendan Harney
Postdoctoral Research Fellow
Centre de recherche du Centre hospitalier de l’Université de Montreal

INFECTIOUS SYPHILIS TEST UPTAKE AND POSITIVITY AMONG AUSTRALIAN WOMEN EVER PRESCRIBED OPIOID AGONIST THERAPY

11:15 AM - 11:20 AM

Abstract (.pdf)

Biography

Ms Paulina Cortez
Project Coordinator And Researcher
Harm Reduction International

BARRIERS, GAPS, AND GLOBAL TRENDS: ADVANCING HEPATITIS ELIMINATION FOR PEOPLE WHO USE DRUGS

11:20 AM - 11:25 AM

Abstract (.pdf)

Biography

Paulina is the Project Coordinator and Researcher in the Public Health and Social Policy team at Harm Reduction International (HRI). She is a gender and drug policy specialist, researcher, and human rights advocate with a background in promoting social justice.
Dr. Ahmed Bayoumi
Professor
University Of Toronto

CLOSING SUPERVISED CONSUMPTION SITES IN TORONTO, CANADA: ESTIMATING HOW MANY PEOPLE WILL LOSE ACCESS

11:25 AM - 11:30 AM

Abstract (.pdf)

Biography

Ahmed Bayoumi is a general internist and clinician scientist. He holds the Baxter and Alma Ricard Chair in Inner City Health at St. Michael's Hospital. His research interests include the delivery of health services, particularly to people who use drugs, people living with HIV, and other marginalized populations.
Dr Kennedy Kipkoech
Senior Research Associate
University of Bristol

MODELLING THE IMPACT OF HEPATITIS C (HCV) TESTING AND TREATMENT ON HCV INCIDENCE AMONG PEOPLE WHO INJECT DRUGS IN ENGLAND

11:30 AM - 11:35 AM

Abstract (.pdf)

Biography

Dr Kennedy Kipkoech is a Senior Research Associate in infectious diseases mathematical modelling at the University of Bristol, United Kingdom. His research specialty and interest are in the application of epidemiological, statistical, and mathematical modelling approaches to understand transmission dynamics and control of infectious diseases, particularly HIV and viral hepatitis.
loading